Retaglutide and tirzepatide are newer GLP-1 receptor agonists gaining popularity as effective treatment options for type 2 diabetes. These medications promote insulin secretion from the pancreas, reduce glucagon https://blanchekeqx271352.activoblog.com/47656325/glp-1-receptor-agonists-retaglutide-and-tirzepatide